CClinicalTrials.gg
Status unknownNCT04235127CSRC-EpiUpdated Jan 28, 2020

The Catalonia Suicide Risk Code Epidemiology Study: an Epidemiological Study of Suicide Attempts in Catalonia, Spain

An observational study in Suicide, Attempted, Suicide and Suicide and Self-harm, sponsored by Hospital del Mar Research Institute (IMIM). Status unknown. Open to participants aged 10 Years and older. Per ClinicalTrials.gov, last updated 2020-01-28.

Sponsored by Hospital del Mar Research Institute (IMIM) · Observational

The sponsor has not verified this record recently (last verified Jan 2020), so the status shown — last known as Active, not recruiting — may be out of date.
Study type
Observational
Model
Case-control
Time perspective
Other
Enrollment
186,000
Ages
10 Years and older
Sex
All
01

Study summary

Suicide attempts (SA) constitute a major public health issue worldwide. Research suggests that 2.7% of adult people ever attempt suicide; among children and adolescents this is estimated to be 6.0%. SA are related to subsequent suicide which represents an annual loss of 34.6 million years of life worldwide. Suicide attempts are also related to persistent physical and mental health issues, psychiatric hospitalizations, impaired academic performance, unemployment, partner abuse victimization and perpetration, having children removed by social services, loneliness, relationship difficulties, impaired social functioning and low life satisfaction. Despite this considerable societal impact, there is a lack of epidemiological research focussing on providing suicide attempt surveillance in the population, to inform public health action aimed at reducing risk for suicide attempts in the population, and to provide data-driven support for suicide risk assessment across healthcare settings. To address this shortcoming, the investigators designed the Catalonia Suicide Risk Code Epidemiology study. Using centralized Electronic Healthcare Record data from the entire public healthcare system of Catalonia, Spain, the CSRC-Epi study aims to estimate reliable suicide incidence rates, identify suicide attempt risk factors, and develop validated suicide attempt risk prediction tools.

02

Conditions studied

  • Suicide, Attempted
  • Suicide
  • Suicide and Self-harm

Keywords

  • nested case-control study
  • electronic healthcare records
  • register-based study
  • incidence
  • risk factors
  • risk prediction
  • machine learning techniques
  • inverse probability weighting
  • public health
  • surveillance
  • population-attributable risk proportions
03

In context

Suicide

703 studies on the registry are indexed under Suicide; 184 are open to participants now.

This study's planned enrollment of 186,000 is above the median of 159 across 122 observational studies indexed under Suicide.

Browse Suicide studies →

Lead sponsor

Hospital del Mar Research Institute (IMIM) is the lead sponsor of 7 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

The target population consists of the dynamic cohort of all Catalan residents during the 6-year period 2014-2019.

Inclusion criteria

  • Catalan residency during 2014-2019
  • age 10 or more at end of observation period

Exclusion criteria

Exclusion Criteria:

  • none
05

Study design

Observational model
Case-control
Time perspective
Other
Enrollment
186,000 participants (estimated)
Target follow-up
6 Years
Patient registry
Yes

Groups and cohorts

  • Catalan population

    The target population consists of the dynamic cohort of all Catalan residents during the 6-year period 2014-2019. Annual total population of Catalonia is between 7.5-7.6 million, with annual rates for immigration, emigration, birth and death being \~2.5%, \~1.9%, \~0.9%, and \~0.8%, respectively. Based on these figures, we expect a maximum of \~9.1 million individuals with Catalan residency status on at least one point in time over the 2014-2019 period. However, we expect SA in Catalonia to be extremely rare before the age of 10, in line with findings that self-injurious behaviour generally occurs as from the adolescent period. We will therefore exclude cases and controls that have not reached age 10 by the end of the 2014-2019 period (i.e., \~10.9%), lowering the total expected target population to \~8.1 million.

    Other: sociodemographic variables, somatic conditions, mental disorders, treatment and drug use

Interventions

  • Othersociodemographic variables, somatic conditions, mental disorders, treatment and drug use

    * sociodemographic variables * history of self-injurious behaviours; all types of somatic conditions; neurodevelopmental, mental, behavioural, personality and substance use disorders; all types of medical procedures performed; and number and type of healthcare contacts. * prescriptions for psychopharmacological products * the Suicidal Scale of the Mini-International Neuropsychiatric Interview, the type and lethality of the attempt that warranted evaluation, presence and type of mental disorder, hopelessness, impulsivity, aggressiveness, altered state of conscience, use or dependence of alcohol, use or dependence of illicit drugs, serious somatic disease (including chronic diseases, chronic pain, and disabilities), living status, presence of family or social support, social problems, stressful life events, access to lethal means, and family history of suicide

06

What researchers measure

Primary outcomes

  1. Number of catalan residents with suicide attempt (incidence)

    Suicide attempt is a nonfatal, self-directed, potentially injurious behaviour with a non-zero degree of intent to die as a result of the behaviour, even if the behaviour does not result in injury

    Time frame: 2014-2019

Secondary outcomes

  1. Number of Catalan residents committing suicide (incidence)

    Suicide is a fatal, self-directed, injurious behaviour with a non-zero degree of intent to die as a result of the behaviour

    Time frame: 2014-2019

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Mortier P, Vilagut G, Puertolas Gracia B, De Ines Trujillo A, Alayo Bueno I, Ballester Coma L, Blasco Cubedo MJ, Cardoner N, Colls C, Elices M, Garcia-Altes A, Gene Badia M, Gomez Sanchez J, Martin Sanchez M, Morros R, Prat Pubill B, Qin P, Mehlum L, Kessler RC, Palao D, Perez Sola V, Alonso J; CODIRISC Epidemiology Study Group. Catalonia Suicide Risk Code Epidemiology (CSRC-Epi) study: protocol for a population-representative nested case-control study of suicide attempts in Catalonia, Spain. BMJ Open. 2020 Jul 12;10(7):e037365. doi: 10.1136/bmjopen-2020-037365. PubMed 32660952 ↗

Related links

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 28, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04235127
Lead sponsor
Hospital del Mar Research Institute (IMIM)
Collaborators
Catalan Agency for Health Information, Assessment and Quality, National Centre for Suicide Research and Prevention, Norway, Harvard Medical School (HMS and HSDM)
Responsible party
Jordi Alonso (M.D., Ph.D., Coordinator of the Health Services Research Group, Director of the Epidemiology and Public Health Program, Hospital del Mar Research Institute (IMIM)) — Principal investigator
First posted
Jan 21, 2020
Start date
Jun 2014
Primary completion
Dec 2019
Last update
Jan 28, 2020

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion